130 related articles for article (PubMed ID: 30732948)
41. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma.
Park MJ; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2018 Mar; 92():69-76. PubMed ID: 29428866
[TBL] [Abstract][Full Text] [Related]
43. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
Chen MM; Colevas AD; Megwalu U; Divi V
Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
[TBL] [Abstract][Full Text] [Related]
44. Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma.
Sano D; Yabuki K; Takahashi H; Arai Y; Chiba Y; Tanabe T; Nishimura G; Oridate N
Auris Nasus Larynx; 2018 Aug; 45(4):846-853. PubMed ID: 29203318
[TBL] [Abstract][Full Text] [Related]
45. Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.
Farsi NJ; Rousseau MC; Schlecht N; Castonguay G; Allison P; Nguyen-Tan PF; Souliéres D; Coutlée F; Hier M; Madathil S; Franco EL; Nicolau B
Carcinogenesis; 2017 Dec; 38(12):1188-1195. PubMed ID: 29029021
[TBL] [Abstract][Full Text] [Related]
46. Socioeconomic position and survival after lung cancer: Influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010.
Dalton SO; Steding-Jessen M; Jakobsen E; Mellemgaard A; Østerlind K; Schüz J; Johansen C
Acta Oncol; 2015 May; 54(5):797-804. PubMed ID: 25761702
[TBL] [Abstract][Full Text] [Related]
47. Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.
Łasińska I; Kolenda T; Teresiak A; Lamperska KM; Galus Ł; Mackiewicz J
Anticancer Agents Med Chem; 2019; 19(3):290-303. PubMed ID: 30198439
[TBL] [Abstract][Full Text] [Related]
48. Impact of elective neck dissection vs observation on regional recurrence and survival in cN0-staged patients with squamous cell carcinomas of the upper aerodigestive tract.
Canis M; Plüquett S; Ihler F; Matthias C; Kron M; Steiner W
Arch Otolaryngol Head Neck Surg; 2012 Jul; 138(7):650-5. PubMed ID: 22801889
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of oral HPV infection among healthy individuals and head and neck cancer cases in the French West Indies.
Auguste A; Gaëte S; Herrmann-Storck C; Michineau L; Joachim C; Deloumeaux J; Duflo S; Luce D
Cancer Causes Control; 2017 Nov; 28(11):1333-1340. PubMed ID: 28948421
[TBL] [Abstract][Full Text] [Related]
50. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
Wu F; Wu LL; Zhu LX
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
[No Abstract] [Full Text] [Related]
51. Socioeconomic factors affect the selection of proton radiation therapy for children.
Shen CJ; Hu C; Ladra MM; Narang AK; Pollack CE; Terezakis SA
Cancer; 2017 Oct; 123(20):4048-4056. PubMed ID: 28654202
[TBL] [Abstract][Full Text] [Related]
52. Fish/shellfish intake and the risk of head and neck cancer.
McClain KM; Bradshaw PT; Khankari NK; Gammon MD; Olshan AF
Eur J Cancer Prev; 2019 Mar; 28(2):102-108. PubMed ID: 29406335
[TBL] [Abstract][Full Text] [Related]
53. Association between 11 genetic polymorphisms in folate-metabolising genes and head and neck cancer risk.
Galbiatti AL; da Silva LM; Ruiz-Cintra MT; Raposo LS; Maníglia JV; Pavarino EC; Goloni-Bertollo EM
Eur J Cancer; 2012 Jul; 48(10):1525-31. PubMed ID: 22051736
[TBL] [Abstract][Full Text] [Related]
54. A population-based study of the influence of socioeconomic status on prostate cancer diagnosis in Taiwan.
Wu CC; Lin CH; Chiang HS; Tang MJ
Int J Equity Health; 2018 Jun; 17(1):79. PubMed ID: 29903010
[TBL] [Abstract][Full Text] [Related]
55. Promising link of HLA-G polymorphism, tobacco consumption and risk of Head and Neck Squamous Cell Carcinoma (HNSCC) in North Indian population.
Agnihotri V; Gupta A; Kumar R; Upadhyay AD; Dwivedi S; Kumar L; Dey S
Hum Immunol; 2017 Feb; 78(2):172-178. PubMed ID: 28040535
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
57. Impact of obesity on outcomes for patients with head and neck cancer.
Hicks DF; Bakst R; Doucette J; Kann BH; Miles B; Genden E; Misiukiewicz K; Posner M; Gupta V
Oral Oncol; 2018 Aug; 83():11-17. PubMed ID: 30098765
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathologic characteristics of head and neck squamous cell carcinoma in Puerto Ricans.
Busquets JM; García HA; Trinidad-Pinedo J; Baez A
P R Health Sci J; 2003 Sep; 22(3):259-64. PubMed ID: 14619452
[TBL] [Abstract][Full Text] [Related]
59. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
60. Head and neck squamous cell carcinoma in people living with HIV in France.
Picard A; Arowas L; Piroth L; Heard I; Ferry T;
Med Mal Infect; 2018 Dec; 48(8):503-508. PubMed ID: 29887186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
